2000
DOI: 10.1067/mjd32000.106512
|View full text |Cite
|
Sign up to set email alerts
|

Sustained improvement of the quality of life of patients with psoriasis after hospitalization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
7
0
2

Year Published

2002
2002
2006
2006

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 0 publications
3
7
0
2
Order By: Relevance
“…The change in DLQI scores over time was significantly different between patients who improved and those who remained unchanged or got worse, and this held true also for separate groups based on gender or age range. Our findings also corroborate previous studies showing that the quality of life of psoriatic in‐patients as measured by the DLQI is significantly improved 1–12 weeks after discharge 13,21–24 …”
Section: Discussionsupporting
confidence: 91%
“…The change in DLQI scores over time was significantly different between patients who improved and those who remained unchanged or got worse, and this held true also for separate groups based on gender or age range. Our findings also corroborate previous studies showing that the quality of life of psoriatic in‐patients as measured by the DLQI is significantly improved 1–12 weeks after discharge 13,21–24 …”
Section: Discussionsupporting
confidence: 91%
“…Not only was infliximab highly effective in treating the disease, but the intravenous form of delivery was well accepted by this patient population, with the majority of patients treated with infliximab stating that their skin treatment was no longer a problem at week 10. The overall improvement in DLQI scores among patients receiving three infusions of infliximab was similar to the improvement reported by patients who had been hospitalized for psoriasis 18,19 …”
Section: Discussionsupporting
confidence: 64%
“…Induction therapy with infliximab significantly improved the HRQOL of patients with severe plaque psoriasis. Patients who participated in the study had baseline DLQI scores that were similar to 18,19 or worse than 20 those of patients participating in other studies of therapy for psoriasis. After receiving only three doses of infliximab, patients reported a significant reduction in the impact of psoriasis on all aspects of HRQOL assessed by DLQI, including daily activities, social functioning, personal relationships, and work or study.…”
Section: Discussionmentioning
confidence: 99%
“…The mean DLQI score before camouflage advice was 9·1. This compares with mean DLQI scores from other skin disorders such as psoriasis (8·7), atopic dermatitis (12·5), alopecia (8·3) and urticaria (8·4), suggesting that the conditions encountered in our study cause disability comparable with that of common dermatoses 7–10 . Although the mean scores of all 10 DLQI questions fell following camouflage advice, suggesting a benefit from attendance at a cosmetic camouflage clinic, a number of study limitations must be considered.…”
Section: Discussionmentioning
confidence: 53%